Form 8-K · Item 4.01 · Auditor change
OptimizeRx Corp: auditor change, UHY LLP to Grant Thornton LLP
OptimizeRx Corp reported in a Form 8-K filed March 30, 2026, that on March 25, 2026, UHY LLP was dismissed as its certifying accountant, and Grant Thornton LLP was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
on March 25, 2026 subsequently dismissed, UHY LLP (“UHY”) as the Company’s independent registered public accounting firm, effective immediately.
there were (1) no “disagreements”, as such term is described in Item 304(a)(1)(iv) of Regulation S-K promulgated under the Exchange Act, with UHY on any matter of accounting principles or practices
On March 26, 2026, the Company and the Audit Committee engaged Grant Thornton LLP (“Grant Thornton”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, effective immediately.
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | OptimizeRx Corp |
|---|---|
| Ticker | OPRX |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | March 30, 2026 |
| What the filing states | dismissed, engaged |
| Former accountant | UHY LLP |
| New accountant | Grant Thornton LLP |
| Date of the change | March 25, 2026 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001448431-26-000007 |
| SEC CIK | 0001448431 |
OptimizeRx Corp reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed March 30, 2026. The filing's own words are quoted above.
Sources
More: all auditor changes · OptimizeRx Corp's CFO record · Something wrong? Send a correction with the primary source.